ConductScience.org, home

Paper22492479

Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.

Donaldson MG and 5 others. J Bone Miner Res, 2012. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial. Papers, record 22492479. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22492479

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
PubMed
Journal
J Bone Miner Res
PubMed
Year
2012
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.53
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Donaldson MGMeghan G
2Palermo LLisa
3Ensrud KEKristine E
4Hochberg MCMarc C
5Schousboe JTJohn T
6Cummings SRSteven R

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AlendronateMajor topic
Bone DensityMajor topic
Femoral Neck FracturesMajor topic
Femur NeckMajor topic
Risk AssessmentMajor topic
Aged
Aged, 80 and over
Bone Density Conservation Agents
Confidence Intervals
Female
Humans
Middle Aged
Placebos
Spinal Fractures

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42024268Revised Swedish FRAX models and the establishment of age-dependent intervention thresholds.Osteoporos Int2026https://conductscience.org/library/papers/42024268PubMed
401341072024 Royal Australian College of General Practitioners and Healthy Bones Australia guideline for osteoporosis management and fracture prevention in postmenopausal women and men over 50 years of age.Med J Aust2025https://conductscience.org/library/papers/40134107PubMed
38086988Effectiveness of romosozumab in patients with osteoporosis at high fracture risk: a Japanese real-world study.J Bone Miner Metab2024https://conductscience.org/library/papers/38086988PubMed
37874461An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis.J Endocrinol Invest2024https://conductscience.org/library/papers/37874461PubMed
37130601
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
BMJ2023https://conductscience.org/library/papers/37130601PubMed
36945065
Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Syst Rev2023https://conductscience.org/library/papers/36945065PubMed
34130365Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial.J Bone Metab2021https://conductscience.org/library/papers/34130365PubMed
33537844Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study.Osteoporos Int2021https://conductscience.org/library/papers/33537844PubMed
33082721The Effect of Type of Femoral Component Fixation on Mortality and Morbidity after Hip Hemiarthroplasty: A Systematic Review and Meta-Analysis.HSS J2020https://conductscience.org/library/papers/33082721PubMed
31009947Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review.Ann Intern Med2019https://conductscience.org/library/papers/31009947PubMed
30382424A brief history of FRAX.Arch Osteoporos2018https://conductscience.org/library/papers/30382424PubMed
30324412European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Osteoporos Int2019https://conductscience.org/library/papers/30324412PubMed
29869039Review of the guideline of the American College of Physicians on the treatment of osteoporosis.Osteoporos Int2018https://conductscience.org/library/papers/29869039PubMed
28474780The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study.J Bone Miner Res2017https://conductscience.org/library/papers/28474780PubMed
26768394Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.Gerontologist2016https://conductscience.org/library/papers/26768394PubMed
26593163Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate.Saudi Med J2015https://conductscience.org/library/papers/26593163PubMed
26564226The real enemy is fragility fracture, not osteoporosis.Osteoporos Int2016https://conductscience.org/library/papers/26564226PubMed
25199574Goal-directed treatment of osteoporosis in Europe.Osteoporos Int2014https://conductscience.org/library/papers/25199574PubMed
24994809Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study.BMJ2014https://conductscience.org/library/papers/24994809PubMed
24577348The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.Osteoporos Int2014https://conductscience.org/library/papers/24577348PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22492479

GET https://conductscience.org/api/papers/v1/22492479/cited_by?page=2